>全球转染市场，按类型（瞬时转染、稳定转染）、方法（非病毒方法、病毒方法）、CRISPR 转染方法（非病毒方法、病毒方法）、产品（试剂和试剂盒、仪器、软件）、生物（哺乳动物细胞、植物、真菌、病毒、细菌）、分子类型（质粒 DNA、小干扰 RNA (siRNA)、蛋白质、DNA 寡核苷酸、核糖核蛋白复合物 (RNP)、其他）、应用（体外应用、体内应用、生物生产、其他）、阶段（研究、临床前、临床阶段、商业）、最终用户（生物制药、合同研究组织 (CRO)、合同制造组织/合同开发和制造组织 (CMO/CDMO)、学术界、医院、临床实验室、其他）、分销渠道（直接招标、零售销售、其他）– 行业趋势和预测到 2031 年。
转染市场分析和规模
根据美国疾病控制与预防中心 2022 年 3 月的出版物，60% 的美国成年人患有慢性病。包括癌症和慢性肺病在内的患病率不断上升，凸显了转染技术在推进治疗方面的重要作用。针对慢性病的创新促进了医疗保健需求的不断增长，促进了转染市场的增长及其在塑造未来治疗干预方面的关键作用。
Data Bridge Market Research 分析，全球转染市场在 2023 年为 12.1858 亿美元，预计到 2031 年将达到 25.371 亿美元，预计在 2024 年至 2031 年的预测期内复合年增长率为 9.6%。这表明市场价值。试剂和试剂盒部分主导全球转染市场的产品部分，在提高基因实验效率方面发挥着至关重要的作用。这些基本组成部分对优化各种基因研究中的转染过程做出了重要贡献。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
转染市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022 (可定制为 2016-2021) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（瞬时转染、稳定转染）、方法（非病毒方法、病毒方法）、CRISPR 转染方法（非病毒方法、病毒方法）、产品（试剂和试剂盒、仪器、软件）、生物体（哺乳动物细胞、植物、真菌、病毒、细菌）、分子类型（质粒 DNA、小干扰 RNA (siRNA)、蛋白质、DNA 寡核苷酸、核糖核蛋白复合物 (RNP)、其他）、应用（体外应用、体内应用、生物生产、其他）、阶段（研究、临床前、临床阶段、商业）、最终用户（生物制药、合同研究组织 (CRO)、合同制造组织/合同开发和制造组织 (CMO/CDMO)、学术界、医院、临床实验室、其他）、分销渠道（直接招标、零售、其他） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。 |
|
涵盖的市场参与者 |
Mirus Bio LLC.（美国）、Promega Corporation（美国）、Polyplus（法国）、Bio-Rad Laboratories, Inc.（美国）、Merck KGaA（德国）、Lonza（瑞士）、MaxCyte.（美国）、Altogen Biosystems（美国）、SBS Genetech（中国）、FUJIFILM Irvine Scientific.（美国）、Croda International Plc.（英国）、PerkinElmer Inc.（美国）、Cytiva（美国）、Geno Technology Inc.（美国）、R&D Systems, Inc.（美国）、Takara Bio Inc.（日本）、Thermo Fisher Scientific Inc.（美国）、F. Hoffmann-La Roche Ltd（瑞士）、QIAGEN（德国）、OriGene Technologies, Inc.（美国） |
|
市场机会 |
|
市场定义
转染是一种实验室技术，涉及将遗传物质（例如 DNA、RNA 或蛋白质）引入真核细胞。此过程允许操纵细胞功能以用于研究、基因治疗和生物技术应用。转染方法包括化学、物理或病毒方法，有助于研究和修改细胞过程。
全球转染市场动态
驱动程序
- 基因治疗需求不断增长
基因治疗需求的不断增长推动了转染市场的发展，而这得益于人们对研究和开发的兴趣和投资的增加。有效的基因传递方法对于治疗突破至关重要，转染技术是推动该领域发展的关键工具，并将基因发现转化为创新和有针对性的治疗干预措施。
- Developing Biopharmaceutical Industry For Efficient Manufacturing
The growing biopharmaceutical sector, emphasizing protein expression and production, is propelling transfection technologies. These methods play a pivotal role in optimizing cell lines for efficient biologics manufacturing. As the industry grows, the demand for advanced transfection techniques rises, contributing to the development and production of biopharmaceuticals with enhanced therapeutic potential.
Opportunities
- Technology Advancements for Efficient Delivery of Genetic Materials
The ever-advancing CRISPR technology is reshaping gene editing, offering new possibilities for transfection methods. This synergy creates opportunities for precise and efficient delivery of genetic materials, expanding applications across diverse fields. The evolving landscape signifies a potential revolution in genetic research, therapeutics, and biotechnology, driven by the synergy of CRISPR and transfection methodologies.
- Increasing Applications In Stem Cell Research
Transfection technologies play a pivotal role in stem cell research by enabling precise genetic modifications. As stem cell research advances, transfection becomes crucial for manipulating and studying stem cells. This contributes significantly to therapeutic applications, enhances the understanding of versatile cells, playing a pivotal role in driving progress in stem cell research for both therapeutic, and research purposes.
Restraints/Challenges
- Cost Constraints Limits Accessibility And Adoption
Cost constraints pose a significant barrier to the transfection market. The expenses associated with transfection reagents, equipment, and technologies hinder accessibility and adoption, especially in research settings with limited budgets. This financial challenge influences the market's growth by limiting the widespread adoption of transfection methods and technologies.
- Cytotoxicity Concerns Impact Cell Viability
Cytotoxicity concerns pose a significant challenge to the transfection market, as certain methods may adversely affect cell viability. This limitation can impede the widespread adoption of specific transfection techniques, hindering their utility and restricting their application in diverse genetic research and therapeutic endeavors.
This global transfection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global transfection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In September 2022, Polyplus, a prominent provider of upstream solutions for biologic and cell and gene therapy, expanded its mRNA support portfolio. The launch of in vivo-jetRNA+ transfection reagent enhances in vivo mRNA delivery with a preformed liposome. This addition signifies Polyplus' commitment to advancing efficient and precise transfection methods in the field of gene therapy
- In February 2022, Mirus Bio, a key player in delivery solutions under Gamma Biosciences, launched the TransIT-VirusGEN SELECT Transfection Kits. Specifically designed for large-scale viral vector production, these kits cater to the demands of cell and gene therapy applications, showcasing Mirus Bio's commitment to advancing efficient and scalable transfection solutions in the biotechnology industry
- In August 2021, Mirus Bio, a prominent player in transfection technologies, launched viral vector transfection kits tailored for cell and gene therapy manufacturing. These specialized transfection reagents aim to optimize the delivery of packaging and transfer vector DNA to suspension, enhancing the production of recombinant adeno-associated virus (AAV) and lentivirus (LV) vectors
- In November 2020, Thermo Fisher Scientific Inc. partnered with Northeastern University, enhancing innovation in the biopharmaceutical industry, particularly in gene and cell therapies. By consistently developing advanced reagents and techniques, the collaboration aimed to bolster sensitivity and accuracy in experiments and drug development, contributing to the production of valuable and efficient tools crucial for the transfection process
Global Transfection Market Scope
The global transfection market is segmented on the basis of type, methods, CRISPR transfection methods, products, organism, types of molecule, application, stage, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Transient Transfection
- Stable Transfection
Methods
- Non-Viral Methods
- Viral Methods
CRISPR Transfection Methods
- Non-Viral Methods
- Viral Methods
Products
- Reagent and Kits
- Instrument
- Software
Organism
- Mammalian Cells
- Plants
- Fungi
- Virus
- Bacteria
Types of Molecule
- Plasmid DNA
- Small Interfering RNA (siRNA)
- Proteins
- DNA Oligonucleotides
- Ribonucleoprotein Complexes (RNPs)
- Others
Application
- In Vitro Application
- In Vivo Application
- Bioproduction
- Others
Stage
- Research
- Preclinical
- Clinical Phases
- Commercial
End User
- Biopharma
- Contract Research Organizations (CROs)
- Contract Manufacturing Organization/ Contract Development
- Manufacturing Organization (CMOs/CDMOs)
- Academia
- Hospitals
- Clinical Labs
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Others
Global Transfection Market Regional Analysis/Insights
The global transfection market is analysed and market size insights and trends are provided by country, type, methods, CRISPR transfection methods, products, organism, types of molecule, application, stage, end user and distribution channel as referenced above.
The countries covered in the global transfection market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region holds the largest share in the global transfection market, with the U.S. leading due to a concentration of numerous companies. The robust presence of these entities contributes significantly to the region's dominance, reflecting a key stronghold in the transfection market's growth and market dynamics.
Europe dominates the global transfection market, with Germany leading the region. The country's strong emphasis on genetic research and protein production positions it as a key player. In the forecast period from 2024 to 2031, Germany's prominence is expected to contribute significantly to the continued growth and advancements in the transfection market.
Asia-Pacific is expected for the highest growth rate in the global transfection market from 2024 to 2031, driven by escalating genetic research activities. China spearheads this growth, particularly in the transient transfection segment, fueled by extensive applications in transient gene expression, underscoring the region's pivotal role in advancing transfection technologies.
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
全球转染市场还为您提供每个国家/地区资本设备医疗保健支出增长、全球转染市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对全球转染市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。
竞争格局和全球转染市场份额分析
全球转染市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球转染市场的关注有关。
全球转染市场的一些主要参与者包括：
- Mirus Bio LLC.（美国）
- Promega 公司 (美国)
- Polyplus（法国）
- Bio-Rad Laboratories, Inc.（美国）
- 默克集团（德国）
- 龙沙（瑞士）
- MaxCyte。（美国）
- Altogen Biosystems（美国）
- SBS 基因科技（中国）
- 富士胶片尔湾科学公司。（美国）
- Croda International Plc.（英国）
- PerkinElmer Inc.（美国）
- Cytiva (美国)
- Geno Technology Inc.（美国）
- R&D Systems, Inc.（美国）
- Takara Bio Inc.（日本）
- 赛默飞世尔科技公司（美国）
- F. Hoffmann-La Roche Ltd（瑞士）
- QIAGEN（德国）
- OriGene Technologies, Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
